MARKETS / NASDAQ / PETS

NASDAQ · RETAIL-DRUG STORES AND PROPRIETARY STORES · SMALL CAP

Petmed Express Inc. PETS

17 fiscal years on record · USD · FY2025 reported · SEC filings only

Revenue

$179.0M

▼ 21.1% YoY

Net income

$-57.3M

Free cash flow

$-33.0M

In brief

What this company does

The Company markets and sells its products and services directly to consumers through its websites, customer contact centers, and mobile applications. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and personalized AutoShip capabilities. More than 1.9 million customers have purchased from the Company within the last three fiscal years. As of March 31, 2026, it had 189 full-time employees. In April 2023, the Company acquired PetCareRx, Inc., an online supplier of pet medications, foods, and supplies based in New York. Since 1996, PetMeds has served customers across North America.

Written from the business description in PETMED EXPRESS INC's annual report to the U.S. Securities and Exchange Commission, filed 2 June 2026. Every sentence was checked against that document before publication.

Growth

USD 179.0M

Revenue, FY2025 · full 17-year series below

Revenue $M Net income $M

FY2025 · Revenue 179.0 · Net income -57.3

Compound annual growth

Revenue

−10.2%

−10.0%

−2.7%

−1.7%

Returned to shareholders

−90.5%

−75.3%

−48.1%

−37.2%

3 yrs

5 yrs

10 yrs

15 yrs

Revenue compounded at −10.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−32 cents

lost on every revenue dollar

Operating margin Net margin

FY2025 · Operating -32.8% · Net -32.0%

ROE

FY2025 · ROE -100.4%

Gross margin28.1%

Operating margin-32.8%

Net margin-32.0%

Return on assets-49.8%

EBITDAUSD -49.3M

Each USD of equity lost 100 cents this year.

Cash & shareholders

USD 21,000.00

returned in FY2025 · dividends + net buybacks

Free cash flow $M

FY2025 · FCF -33.0

Net buybacks $M Dividends $M

FY2025 · Dividends 0.0 · Net buybacks —

Dividends paidUSD 21,000.00

Net buybacks—

Share of profit-0.0%

Consecutive raises—

USD 21,000.00 in dividends went back to shareholders in a year without profit.

Total assetsUSD 81.2M

EquityUSD 28.9M

CashUSD 21.4M

Current ratio0.84×

Equity funds 36% of total assets.

The 17-year record

17 fiscal years

Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative

Metric	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
Revenue $B	0.2	0.2	0.3	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
Operating income $B	−0.1	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EBITDA $B	−0.0	0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	·	·
Income tax $B	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income $B	−0.1	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Free cash flow $B	−0.0	−0.0	−0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
EPS, diluted $	−2.74	−0.30	−0.37	0.25	0.92	1.19	1.29	1.84	1.82	1.17	1.02	0.87	0.90	0.86	0.80	0.92	1.14
Dividend / sh $	0.00	0.00	0.60	1.20	1.20	1.12	1.08	1.06	0.85	0.76	0.72	0.68	0.66	1.60	0.53	0.47	0.30
Payout %	−0	−3	−167	477	130	95	84	58	47	65	71	79	74	186	66	51	26
ROE %	−100.4	−6.9	−7.2	4.4	15.1	19.5	20.3	30.1	35.7	27.0	25.9	24.0	26.8	23.6	18.7	21.5	26.8
Shares out B	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.02	0.00	0.02	0.02	0.02	0.02	·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Compare

This company against its peers

Petmed Express Inc.vsCVS Health Corp.Same industry: Retail-Drug Stores and Proprietary Stores Petmed Express Inc.vsRidgetech Inc.Same industry: Retail-Drug Stores and Proprietary Stores Petmed Express Inc.vsTrees Corp. (Colorado)Same industry: Retail-Drug Stores and Proprietary Stores Petmed Express Inc.vsAiXin Life International, Inc.Same industry: Retail-Drug Stores and Proprietary Stores

Provenance

Company facts, as filed

How we verify · 0 failures in 82 reconciliationsAUDITED

Reconciled in 17 of 19 fiscal years. 13 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures

ActivityRetail-Drug Stores and Proprietary Stores

Listed onNASDAQ

Incorporated inFlorida

Fiscal year endsMarch 31

SEC categorysmaller reporting company

Data on record since2009